https://www.avient.com/investor-center/news/avient-announces-first-quarter-2022-results-connection-announcement-acquire-dsm-protective-materials-dyneema
The company noted sales growth in nearly all end markets, as it continues to more than offset inflation to deliver record results.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the ability and time required to consummate the acquisition of Dyneema; our ability to achieve the strategic and other objectives relating to the proposed acquisition of Dyneema; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.
https://www.avient.com/products/engineered-polymer-formulations/conductive-signal-radiation-shielding-formulations/edgetek
From design flexibility to easy processing, our customizable materials can dial in specific Dk (Dielectric Constant) /Df (Dissipation Factor) values to meet manufacturing requirements, helping you reduce lead times and increase speed to market.
Accelerated speed to market
Custom Edgetek™ formulation delivered tailored Dk/Df performance and accelerated speed to market
https://www.avient.com/company/sustainability/sustainability-report/products/product-stewardship-global-chemical-management-product-excellence
In addition, for this reporting period there have been zero incidences of product recalls due to non-compliance in the markets we serve.
For our sensitive applications we have implemented Good Manufacturing Processes (GMP) and ISO 13485. 100% of our facilities producing for the healthcare market are GMP or ISO audited within a 3–year period.
https://www.avient.com/investor-center/news/polyone-signs-agreement-divest-performance-products-and-solutions-business-segment
and Automotive end markets.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the time required to consummate the proposed divestiture; the satisfaction or waiver of conditions in the sale agreement; any material adverse changes in the business supporting the PP&S assets being sold; the ability to obtain required regulatory or other third-party approvals and consents and otherwise consummate the proposed divestiture; our ability to identify and evaluate acquisition targets and consummate and integrate acquisitions; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, cost reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/products/thermoplastic-elastomers/versaflex-hc-thermoplastic-elastomers
Marketing + Technical Info
Versaflex™ HC Thermoplastic Elastomers provided a medical-grade TPE to help the customer meet necessary regulatory specifications and gain market share
https://www.avient.com/products/polymer-additives/healthcare-additives/mevopur-healthcare-functional-additives
Marketing + Technical Info
Explore how Avient Healthcare Polymer Colorant and Additive Solutions can support the growing healthcare market trends by helping our customers to manage product performance and risk.
https://www.avient.com/investors/events-presentations?page=3
PolyOne IR Presentation – Fermium Research Marketing Trip – 12/16/2019
PolyOne IR Presentation – KeyBanc Capital Markets Conference – 5/30/2019
https://www.avient.com/investors/events-presentations?page=0
PolyOne IR Presentation – Fermium Research Marketing Trip – 12/16/2019
PolyOne IR Presentation – KeyBanc Capital Markets Conference – 5/30/2019
https://www.avient.com/investors/events-presentations?page=1
PolyOne IR Presentation – Fermium Research Marketing Trip – 12/16/2019
PolyOne IR Presentation – KeyBanc Capital Markets Conference – 5/30/2019
https://www.avient.com/resource-center?document_type=59&document_subtype=127&industry=0&product_family=1688&product_subfamily=0&product_name=0&op=FILTER RESULTS&form_build_id=form-eABbCwp28m0LYQS3A8tRxIzSVnbqlh1x6IrU-oy_f-k&form_id=resource_filter_form
Marketing + Technical Info